Ionis Pharmaceuticals IONS Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's contract liabilities, non-current?
- Ionis Pharmaceuticals (IONS) reported contract liabilities, non-current of $75.75M in Q1 2026.
- How has Ionis Pharmaceuticals's contract liabilities, non-current changed year-over-year?
- Ionis Pharmaceuticals's contract liabilities, non-current decreased by 46.2% year-over-year, from $140.68M to $75.75M.
- What is the long-term trend for Ionis Pharmaceuticals's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's contract liabilities, non-current has grown at a -26.3% compound annual growth rate (CAGR), from $424.05M to $92M.